Loading clinical trials...
Loading clinical trials...
Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from ba...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
ASH Research Collaborative
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT06612268 · Sickle Cell Disease
NCT06215118 · Multiple Myeloma
NCT06679101 · Multiple Myeloma, Newly Diagnosed Multiple Myeloma
NCT06820515 · Hemophilia, Thrombosis, and more
ASH Research Collaborative
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions